Initial and crucial genetic events in intestinal‐type gastric intramucosal neoplasia

• DOI: 10.1002/path.5208
• Publication Date: 2018-11-26T09:15:52Z
• Authors: Hirofumi Rokutan; Hiroyuki Abe; Hiromi Nakamura; Tetsuo Ushiku; Erika Arakawa; Fumie Hosoda; Shinichi Yachida; Yosuke Tsuji; Mitsuhiro Fujishiro; Kazuhiko Koike; Yasushi Totoki; Masashi Fukayama; Tatsuhiro Shibata
• Keywords: Aged, 80 and over; Male; 0301 basic medicine; 0303 health sciences; Genes, APC; Carcinogenesis; High-Throughput Nucleotide Sequencing; Loss of Heterozygosity; Middle Aged; 3. Good health; 03 medical and health sciences; Cell Transformation, Neoplastic; Gastric Mucosa; Stomach Neoplasms; Mutation; Humans; Female; Tumor Suppressor Protein p53; Precancerous Conditions; Aged

AbstractGastric cancer (GC) is one of the most common and life‐threatening malignancies. The course of disease and tumor aggressiveness vary among GCs, although how early fate is determined and by what factors remains elusive. To solve this question, we collected 43 gastric intramucosal neoplasias (GINs), comprising dysplasia/intraepithelial neoplasia (D/IEN; a premalignant lesion) and minute GC (miGC; ≤10 mm) of intestinal histotype and performed targeted deep DNA sequencing of 67 GC‐related genes derived from large‐scale data. Gastric D/IEN was classified into low or high grade (LG‐D/IEN or HG‐D/IEN). The most frequent mutations in D/IENs included APC (19/25; 76%), ARID2 (6/25; 24%) and MUC6 (5/25; 20%). All LG‐D/IENs had APC mutation (12/12) and APC hotspot mutations affecting R1450 and E1554 were noted in both LG‐D/IEN and HG‐D/IEN. ARID2 mutation always co‐occurred with APC mutation, whose tumor variant allele frequency (TVAF) was higher than that of ARID2 in D/IEN. APC and TP53 mutations were mutually exclusive in D/IEN (p = 0.031 [main cohort], p = 0.025 [expanding cohort]) and TP53‐mutated D/IEN was exclusively HG‐D/IEN (4/4). TP53 mutations were highly recurrent (11/14; 79%) in MLH1‐positive miGCs and were detected even in two microscopic lesions measuring 1 and 3 mm, respectively. Furthermore, TVAF analyses suggested that TP53 mutation is the initial event in the TP53‐mutated miGCs. In contrast, TP53 mutation was absent (0/4) in MLH1‐negative small intramucosal carcinoma (8–24 mm). Advanced GC data suggested that early mutations (APC and TP53) may affect the potential of cancerous progression from D/IEN. This study revealed somatic mutational landscape and initial mutations of GINs, and we report for the first time that TP53 mutations precede other mutations in intestinal‐type GC. Our results also indicate that molecular subtyping based on APC/TP53 mutations would be a high‐priority approach for determining and predicting the malignant potential of GIN, including D/IEN. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.